Strategic Acquisitions Driving Growth
The acquisitions of USARad and Nano-X AI have doubled revenues for USARad and transformed Nano-X AI from a pre-revenue business to a growing revenue stream.
Expanding Sales Pipeline
The sales pipeline has doubled since January 2025, with over 1,000 leads and a target of over 100 ARC systems in deployment stages by the end of 2025.
Regulatory Success
Received 510(k) clearance from the FDA for the Nano-X ARC systems, enabling wider deployment.
AI Solutions Momentum
Strong interest and expanding sales pipeline for AI solutions, including a partnership with Ezra AI for use in dozens of locations in the US.
Revenue Growth in Teleradiology
Revenue from teleradiology services increased to $2.6 million, with a gross profit margin of approximately 17% compared to 14% in the previous period.